A prospective study of HIV disease progression in female and male drug users.
A prospective study of HIV disease progression in female and male drug users.
复制标题
女性和男性吸毒者艾滋病毒疾病进展的前瞻性研究。
DOI:
10.1097/00002030-199902040-00014
复制
发表时间:
1999
期刊:
影响因子:
--
通讯作者:
Klein,RS
中科院分区:
文献类型:
--
作者:
Webber,MP;Schoenbaum,EE;Gourevitch,MN;Buono,D;Klein,RS
Objective:To compare HIV disease progression and mortality in a cohort of female and male drug users.Design:A prospective cohort study of 222 HIV-seropositive women and 302 HIV-seropositive men who attended a hospital-affiliated methadone maintenance program with on-site primary care.Methods:Regression slopes of CD4+ cell decline were compared using the two sample t-test, and the distribution of AIDS-defining illnesses evaluated by Mantel-Haenszel χ 2 test. Time to AIDS-defining clinical conditions and death were compared using the Kaplan-Meier log-rank test. Multivariate estimates of progression to clinical AIDS or death, for all participants, stratified by sex, were derived from Cox proportional hazards models.Results:Ninety-five persons (43 women and 52 men) developed AIDS-defining conditions. Analyses of the rates of CD4+ cell decline, the distribution of first AIDS-defining illnesses, and the time to clinical AIDS did not differ by sex. In the multivariate model, sex was not associated with an AIDS outcome, whereas crack-cocaine use [hazards ratio (HR), 1.815; 95% confidence interval (CI), 1.151-2.863], CD4+ cell count (100× 10 6/l; HR, 0.589; 95% CI, 0.511-0.679), and two or more HIV-related symptoms (HR, 1.702; 95% CI, 1.125-2.576) were associated. Mortality rates (8.71 per 100 person-years in women and 9.85 per 100 person-years in men) were similar, using univariate or multivariate methods.Conclusions:There was little difference in clinical outcomes or mortality between HIV-seropositive female and male drug users with access to primary care. However, crack-cocaine use was independently associated with progression to clinical AIDS.
登录
查看更多内容
DOI:
--
发表时间:
1992
期刊:
AIDS (London)
影响因子:
--
作者:
Philippe Morlat;P. Parneix;D. Douard;D. Lacoste;M. Dupon;G. Chêne;J. Pellegrin;J. Ragnaud;F. Dabis
通讯作者:
F. Dabis
DOI:
--
发表时间:
1995
期刊:
Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association
影响因子:
--
作者:
Galai,N;Vlahov,D;Margolick,JB;Chen,K;Graham,NM;Muñoz,A
通讯作者:
Muñoz,A
影响因子:
158.5
作者:
B. Edlin;K. Irwin;S. Faruque;C. Mccoy;C. Word;Y. Serrano;J. Inciardi;B. Bowser;R. Schilling;S. Holmberg
通讯作者:
S. Holmberg
影响因子:
158.5
作者:
SELWYN, PA;ALCABES, P;FRIEDLAND, GH
通讯作者:
FRIEDLAND, GH
DOI:
--
发表时间:
1992
期刊:
AIDS (London)
影响因子:
--
作者:
A. Greenberg;P. Thomas;S. Landesman;D. Mildvan;M. Seidlin;G. Friedland;R. Holzman;B. Starrett;J. Braun;E. Bryan;R. F. Evans
通讯作者:
R. F. Evans